Stock & Company Details
Emergent Biosolutions Inc $EBS
Price:
N/A
N/A
51M
$364M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.06
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
EBS technical indicators
Latest Emergent Biosolutions Inc (EBS) indicator readings as of 2026-10-29.
EBS's 14-day RSI is 61.5, in neutral territory. At $7.22 it is trading 10.2% below its 200-day moving average of $8.04, and above its 50-day average of $6.43. Price sits near the upper Bollinger Band ($5.98 to $7.47). ADX reads 16.1, indicating a range-bound market rather than a trend.
Overview
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.
Finance Bot
Ask your questions
Start by typing a question below.
